国产成人三级网址在线看_日韩高清在线毛片_精品国内自产拍在线观看尤物_欧美精品 亚洲日韩_成人黄色影片在线看_国产一区二区播放_国产午夜理论最新电影_日本伊人久久综合_亚洲国产网站视频在线播放_日韩人妻系列无码专区

賴氨酰氧化酶樣蛋白2(LOXL2)重組蛋白

Recombinant Lysyl Oxidase Like Protein 2 (LOXL2)

LOR2; WS9-14; Lysyl oxidase homolog 2; Lysyl oxidase-related protein 2; Lysyl oxidase-related protein WS9-14

  • 賴氨酰氧化酶樣蛋白2(LOXL2)重組蛋白 產(chǎn)品包裝(模擬)
  • 賴氨酰氧化酶樣蛋白2(LOXL2)重組蛋白 產(chǎn)品包裝(模擬)
  • RPF552Hu01.jpg SDS-PAGE圖
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

序列

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲(chǔ)存

避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

相關(guān)產(chǎn)品

編號(hào) 適用物種:Homo sapiens (Human,人) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPF552Hu01 賴氨酰氧化酶樣蛋白2(LOXL2)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPF552Hu02 賴氨酰氧化酶樣蛋白2(LOXL2)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAF552Hu01 賴氨酰氧化酶樣蛋白2(LOXL2)多克隆抗體 WB; IHC; ICC; IP.
PAF552Hu02 賴氨酰氧化酶樣蛋白2(LOXL2)多克隆抗體 WB; IHC; ICC; IP.
SEF552Hu 賴氨酰氧化酶樣蛋白2(LOXL2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMF552Hu 賴氨酰氧化酶樣蛋白2(LOXL2)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志 參考文獻(xiàn)
BMC Cancer. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.12 [Pubmed: 24007603]
Current Eye Research High Glucose Induced Differential Expression of Lysyl Oxidase and Its Isoform in ARPE-19 Cells [Pubmed: 22966818]
Curr Eye Res Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-? Levels and LOXL1 Genotype in Pseudoexfoliation [Pubmed:27116380]
BMC Cancer Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study [Pubmed:29558905]
Laryngoscope Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma [Pubmed: 31219623]
留言咨詢